These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22357632)

  • 1. Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of T cell responses.
    Tribulatti MV; Figini MG; Carabelli J; Cattaneo V; Campetella O
    J Immunol; 2012 Apr; 188(7):2991-9. PubMed ID: 22357632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-8 provides costimulatory and proliferative signals to T lymphocytes.
    Tribulatti MV; Cattaneo V; Hellman U; Mucci J; Campetella O
    J Leukoc Biol; 2009 Aug; 86(2):371-80. PubMed ID: 19401394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-8 tandem-repeat structure is essential for T-cell proliferation but not for co-stimulation.
    Cattaneo V; Tribulatti MV; Campetella O
    Biochem J; 2011 Feb; 434(1):153-60. PubMed ID: 21091438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size.
    Liu SD; Tomassian T; Bruhn KW; Miller JF; Poirier F; Miceli MC
    J Immunol; 2009 May; 182(9):5283-95. PubMed ID: 19380775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.
    Dubey C; Croft M; Swain SL
    J Immunol; 1995 Jul; 155(1):45-57. PubMed ID: 7541426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a double-CRD-mutated Gal-8 recombinant protein that retains co-stimulatory activity on antigen-specific T-cell response.
    Schroeder MN; Tribulatti MV; Carabelli J; André-Leroux G; Caramelo JJ; Cattaneo V; Campetella O
    Biochem J; 2016 Apr; 473(7):887-98. PubMed ID: 26795039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
    Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT
    J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
    Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
    J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
    Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
    Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two roles for Ia in antigen-specific T cell activation. II. Toward a Velcro model of antigen recognition.
    Kim KH; Thomas DW
    J Immunol; 1988 Apr; 140(8):2500-7. PubMed ID: 3258611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
    Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
    Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.
    Fukumori T; Takenaka Y; Yoshii T; Kim HR; Hogan V; Inohara H; Kagawa S; Raz A
    Cancer Res; 2003 Dec; 63(23):8302-11. PubMed ID: 14678989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-8 activates dendritic cells and stimulates antigen-specific immune response elicitation.
    Carabelli J; Quattrocchi V; D'Antuono A; Zamorano P; Tribulatti MV; Campetella O
    J Leukoc Biol; 2017 Nov; 102(5):1237-1247. PubMed ID: 28811319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses.
    Wang M; Ellison CA; Gartner JG; HayGlass KT
    J Immunol; 1998 Feb; 160(3):1098-105. PubMed ID: 9570522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
    Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activation of naive T cells by antigen-presenting B cells.
    Morris SC; Lees A; Finkelman FD
    J Immunol; 1994 Apr; 152(8):3777-85. PubMed ID: 8144947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
    Mejri N; Gottstein B
    Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo.
    Constant SL
    J Immunol; 1999 May; 162(10):5695-703. PubMed ID: 10229801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKT cell-dependent regulation of secondary antigen-specific, conventional CD4+ T cell immune responses.
    Shin Y; Hong C; Lee H; Shin JH; Hong S; Park SH
    J Immunol; 2010 May; 184(10):5589-94. PubMed ID: 20375305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.